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Missing outcome data in randomised trials are a major
potential source of bias in trial results, and their correct
handling can be a major source of difficulty for investi-
gators [1]. Missing outcome data matter for three main
reasons:
1. They lead to a loss of power. This cannot be
reversed, and so all efforts should be made to maximise
completeness of follow-up.
2. Any analysis of incomplete data makes untestable
assumptions and is likely to be biased if those assump-
tions do not hold. Because the correct assumption is
usually unknown, it is important to justify the assump-
tion used from subject-matter knowledge, and to per-
form sensitivity analyses.
3. Some popular analysis methods give inefficient esti-
mates and/or biased standard errors, even if their
assumptions are correct.
This talk will outline some of the statistical methods
available for handling missing data in randomised trials,
and what their underlying assumptions are. Some meth-
ods are simple to implement but harder to support: for
example, “Last Observation Carried Forward” is based
on an assumption that is rarely justified, while analysis
of complete cases can be statistically inefficient. More
complex methods such as mixed models and multiple
imputation are usually based around a missing at ran-
dom assumption, which is popular because it is per-
ceived to become more plausible as models become
more complex.
The intention-to-treat principle is sometimes seen as
requiring missing values to be imputed. By focussing
instead on assumptions, I will show that it is sufficient
for all observed data to be included in the main analysis,
but that sensitivity analyses must take account of all
randomised individuals. This approach will be sum-
marised in an intention-to-treat analysis strategy [2].
I will also briefly describe how to perform a sensitivity
analysis and how to handle missing baseline variables.
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